October 3, 2022
Loading...
You are here:  Home  >  Banking & Finance  >  Tri-County Public Companies  >  Earnings  >  Current Article

Analysts bullish on Amgen and stock soars

IN THIS ARTICLE

Analyst assessments are out on Amgen’s second quarter performance, and the comments sent the Thousand Oaks biotech giant’s stock on an upward track. The notes to investors drew attention to the company’s struggling core business, but called its pipeline of new products “promising.” Shares are more than $10 higher after the company’s earnings report July…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.